Contact Us

DESTINATION NEWS

Duke-NUS marks 20 years with transformative S$30m in philanthropic gifts and pledges to boost next-gen medical breakthroughs

Jan 13, 2025

The legacy of Duke-NUS\' founding donor,the Estate of Khoo Teck Puat,continues with a transformative S$5.5 million gift towards research.

Ultima Markets Wins "Best APAC CFD Broker 2024" Award, Setting New Standards in the Trading Industry

Jan 11, 2025

HONG KONG,Jan. 10,2025-- Ultima Markets celebrated a landmark evening for the financial trading industry as the Traders Fair concluded in grand style. This globally recognised event brought traders,i

SN BioScience Propels SNB-101 to Phase 2 with IND Clearance from FDA

Jan 11, 2025

SEOUL,South Korea,Jan. 10,2025-- SNBioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for a

Harbour BioMed Announces License Agreement with Windward Bio for HBM9378/SKB378, an Anti-TSLP Fully Human Antibody for Immunological Diseases

Jan 11, 2025

CAMBRIDGE,Mass.,ROTTERDAM,Netherlands and SHANGHAI,Jan. 10,2025--Harbour BioMed (HKEX: 02142,the "Company"),a global biopharmaceutical company committed to the discovery,development and com

China Telecom's TeleNavi: Voice-Only Intelligent Location Technology Helps to Break Through 'The Digital Travel Dilemma' For the Elderly

Jan 11, 2025

HONG KONG,Jan. 10,2025-- The \'Digital Travel Dilemma\' of the Elderly The internet is evolving at an unprecedented pace,significantly enhancing convenience for young people,while the elderly are in

Psylo Rebrands as Xylo, with Key Board Appointments and Breakthrough Pipeline Progress

Jan 11, 2025

Announces Major Milestones at the JPM Healthcare Conference SAN FRANCISCO,Jan. 10,2025-- Psylo,a leader in neurotherapeutics discovery and development,has officially rebranded as Xylo Bio. This transf

1 ... 126 127 128 129 130 131 132 ... 344